The Money Is In The Thinking (guest: Morris Sachs)
The Market Huddle
00:00
The Mid-Cap Biotechs Aren't Getting Much Love, Right?
I want to highlight just how weak the subgroups, the smaller mid-caps and all these different things. The biotechs, the health care in general, XLV, had a great run. But then you take a look at the basket of the kind of more mid-cap biotechs in the XBI and it hasn't moved. Well, listen, the whole market's kind of stuck in wind, so not much is going up right now.
Play episode from 01:56:06
Transcript
